3-69118895-A-G

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate

The NM_198271.5(LMOD3):​c.1460T>C​(p.Val487Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000466 in 1,608,792 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.000014 ( 0 hom., cov: 30)
Exomes 𝑓: 0.000050 ( 0 hom. )

Consequence

LMOD3
NM_198271.5 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 2.40

Publications

0 publications found
Variant links:
Genes affected
LMOD3 (HGNC:6649): (leiomodin 3) The protein encoded by this gene is a member of the leiomodin family of proteins. This protein contains three actin-binding domains, a tropomyosin domain, a leucine-rich repeat domain, and a Wiskott-Aldrich syndrome protein homology 2 domain (WH2). Localization of this protein to the pointed ends of thin filaments has been observed, and there is evidence that this protein acts as a catalyst of actin nucleation, and is important to the organization of sarcomeric thin filaments in skeletal muscles. Mutations in this gene have been associated as one cause of Nemaline myopathy, as other genes have also been linked to this disorder. Nemaline myopathy is a disorder characterized by nonprogressive generalized muscle weakness and protein inclusions (nemaline bodies) in skeletal myofibers. Patients with mutations in this gene often present with a severe congenital form of the disorder. [provided by RefSeq, Jan 2015]
LMOD3 Gene-Disease associations (from GenCC):
  • nemaline myopathy 10
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P
  • typical nemaline myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • severe congenital nemaline myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.08616409).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LMOD3NM_198271.5 linkc.1460T>C p.Val487Ala missense_variant Exon 2 of 3 ENST00000420581.7 NP_938012.2 Q0VAK6-1
LMOD3NM_001304418.3 linkc.1460T>C p.Val487Ala missense_variant Exon 3 of 4 NP_001291347.1 Q0VAK6-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LMOD3ENST00000420581.7 linkc.1460T>C p.Val487Ala missense_variant Exon 2 of 3 1 NM_198271.5 ENSP00000414670.3 Q0VAK6-1
LMOD3ENST00000475434.1 linkc.1460T>C p.Val487Ala missense_variant Exon 3 of 4 5 ENSP00000418645.1 Q0VAK6-1
LMOD3ENST00000489031.5 linkc.1460T>C p.Val487Ala missense_variant Exon 3 of 4 2 ENSP00000417210.1 Q0VAK6-1

Frequencies

GnomAD3 genomes
AF:
0.0000136
AC:
2
AN:
147178
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000300
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000201
AC:
5
AN:
248486
AF XY:
0.0000148
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000445
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000499
AC:
73
AN:
1461614
Hom.:
0
Cov.:
33
AF XY:
0.0000454
AC XY:
33
AN XY:
727084
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33474
American (AMR)
AF:
0.0000224
AC:
1
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26128
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39672
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86248
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53398
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
0.0000612
AC:
68
AN:
1111834
Other (OTH)
AF:
0.0000663
AC:
4
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
5
10
15
20
25
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000136
AC:
2
AN:
147178
Hom.:
0
Cov.:
30
AF XY:
0.00
AC XY:
0
AN XY:
71518
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
39690
American (AMR)
AF:
0.00
AC:
0
AN:
14618
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3440
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5082
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4318
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10150
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000300
AC:
2
AN:
66686
Other (OTH)
AF:
0.00
AC:
0
AN:
1970
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000141
Hom.:
0
Bravo
AF:
0.0000264
ExAC
AF:
0.0000330
AC:
4
EpiCase
AF:
0.000109
EpiControl
AF:
0.00

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Nemaline myopathy 10 Uncertain:1
Jun 19, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces valine, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 487 of the LMOD3 protein (p.Val487Ala). This variant is present in population databases (rs745318870, gnomAD 0.005%). This variant has not been reported in the literature in individuals affected with LMOD3-related conditions. ClinVar contains an entry for this variant (Variation ID: 475306). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

not provided Uncertain:1
Nov 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

LMOD3: PM2, BP4 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.34
T
BayesDel_noAF
Benign
-0.56
CADD
Benign
14
DANN
Benign
0.85
DEOGEN2
Benign
0.0061
T;T;T
Eigen
Benign
-0.43
Eigen_PC
Benign
-0.30
FATHMM_MKL
Uncertain
0.83
D
LIST_S2
Benign
0.57
.;.;T
M_CAP
Benign
0.0052
T
MetaRNN
Benign
0.086
T;T;T
MetaSVM
Benign
-0.95
T
MutationAssessor
Uncertain
2.1
M;M;M
PhyloP100
2.4
PrimateAI
Benign
0.42
T
PROVEAN
Benign
-0.24
N;N;N
REVEL
Benign
0.029
Sift
Benign
0.20
T;T;T
Sift4G
Benign
0.83
T;T;T
Polyphen
0.022
B;B;B
Vest4
0.29
MVP
0.095
MPC
0.022
ClinPred
0.093
T
GERP RS
3.4
Varity_R
0.054
gMVP
0.40
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs745318870; hg19: chr3-69168046; API